Nature Reviews Immunology, .
Nat Rev Immunol. 2021 Feb;21(2):72. doi: 10.1038/s41577-021-00504-3.
A vaccine based on liposome-formulated uracil-modified mRNA shows promise in mouse models of multiple sclerosis.
基于脂质体制剂化尿嘧啶修饰 mRNA 的疫苗在多发性硬化症的小鼠模型中显示出良好的前景。